文献

J-GLOBAL ID：201602280627502277   整理番号：16A0589651

胃癌のHER2状態と関係した臨床病理学的因子:日本人住民集団における前向き多施設観察コホート試験(JFMC44-1101)からの結果

Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)

著者 (15件)： MATSUSAKA Satoshi (Cancer Inst. Hospital of the Japanese Foundation for Cancer Res., Tokyo, JPN) ,  NASHIMOTO Atsushi (Niigata Prefectural Cancer Center Niigata Hospital, Niigata, JPN) ,  NISHIKAWA Kazuhiro (Osaka General Medical Center, Osaka, JPN) ,  MIKI Akira (Kobe City Medical Center General Hospital, Kobe, JPN) ,  MIWA Hiroto (Hyogo Coll. of Medicine, Nishinomiya, JPN) ,  YAMAGUCHI Kazuya (Gifu Univ. Graduate School of Medicine, Gifu, JPN) ,  YOSHIKAWA Takaki (Kanagawa Cancer Center, Yokohama, JPN) ,  OCHIAI Atsushi (National Cancer Center Hospital East, Chiba, JPN) ,  MORITA Satoshi (Kyoto Univ. Graduate School of Medicine, Kyoto, JPN) ,  SANO Takeshi (Cancer Inst. Hospital of the Japanese Foundation for Cancer Res., Tokyo, JPN) ,  KODERA Yasuhiro (Nagoya Univ. Graduate School of Medicine, Nagoya, JPN) ,  KAKEJI Yoshihiro (Kobe Univ., Kobe, JPN) ,  SAKAMOTO Junichi (Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, JPN) ,  SAJI Shigetoyo (Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, JPN) ,  YOSHIDA Kazuhiro (Gifu Univ. Graduate School of Medicine, Gifu, JPN)
資料名： Gastric Cancer (Web)  (Gastric Cancer (Web))
巻： 19  号： 3  ページ： 839-851 (WEB ONLY)  発行年： 2016年07月 
JST資料番号： U0618A  ISSN： 1436-3291  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： トラスツズマブのオープンラベル,国際多施設,第III相無作為...

シソーラス用語： *胃腫瘍 ,...
準シソーラス用語： *HER2 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0589651&from=J-GLOBAL&jstjournalNo=U0618A") }}

分類 (3件)： 腫ようの薬物療法  (GE03032C) ,  消化器の腫よう  (GH04000D) ,  疫学  (GB03000E)

引用文献 (29件)：

• Cuello M, Ettenberg SA, Clark AS, Keane MM, Posner RH, Nau MM, et al. Down-regulation of the erbB-2 receptor by trastuzumab enhances tumor necrosis factor related apoptosis inducing ligand mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. Cancer Res. 2001;61:4892-900.
• Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial. Lancet. 2010;376:687-97.
• Van Cutsem E, Bang YJ, Feng-yi F, Xu JM, Lee KW, Jiao SC, et al. HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer. Gastric Cancer. 2014. doi:10.1007/s10120-014-0402-y.
• Bang YJ, Chung H, Xu J, Lordick F, Sawaki A, Lipatov O, et al. Pathological features of advanced gastric cancer (GC): relationship to human epidermal growth factor receptor 2 (HER2) positivity in the global screening programme of the ToGA trial. J Clin Oncol. 2009;27:4556.
• Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, et al. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res. 1991;51:1034-8.

タイトルに関連する用語 (9件)： 胃癌 ,  HER2 ,  臨床病理学的因子 ,  日本人 ,  住民 ,  集団 ,  施設 ,  観察 ,  コホート試験